Prognostic Importance of Early Worsening Renal Function After Initiation of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Cardiac Dysfunction
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Background—: Worsening renal function (WRF) in the setting of heart failure has been associated with increased mortality. However, it is unclear if this decreased survival is a direct result of the reduction in glomerular filtration rate (GFR) or if the mechanism underlying the deterioration in GFR is driving prognosis. Given that WRF in the setting of angiotensin-converting enzyme inhibitor (ACE-I) initiation is likely mechanistically distinct from spontaneously occurring WRF, we investigated the relative early WRF-associated mortality rates in subjects randomized to ACE-I or placebo. Methods and Results—: Subjects in the Studies Of Left Ventricular Dysfunction (SOLVD) limited data set (n=6337) were studied. The interaction between early WRF (decrease in estimated GFR ≥20% at 14 days), randomization to enalapril, and mortality was the primary end point. In the overall population, early WRF was associated with increased mortality (adjusted hazard ratio [HR], 1.2; 95% CI, 1.0–1.4; P =0.037). When analysis was restricted to the placebo group, this association strengthened (adjusted HR, 1.4; 95% CI, 1.1–1.8; P =0.004). However, in the enalapril group, early WRF had no adverse prognostic significance (adjusted HR, 1.0; 95% CI, 0.8–1.3; P =1.0; P =0.09 for the interaction). In patients who continued to receive study drug despite early WRF, a survival advantage remained with enalapril therapy (adjusted HR, 0.66; 95% CI, 0.5–0.9; P =0.018). Conclusions—: These data support the notion that the mechanism underlying WRF is important in determining its prognostic significance. Specifically, early WRF in the setting of ACE-I initiation appears to represent a benign event that is not associated with a loss of benefit from continued ACE-I therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. (., Hendriksen, S., Kusek, J. W., & Van Lente, F. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,725
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
THE IMPACT OF CONFOUNDER SELECTION CRITERIA ON EFFECT ESTIMATION
MICKEY, R. M., & GREENLAND, S. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115101 · Cited by 2,362 · cited 1×
“2 were retained.(22) For the primary analyses, modeling was repeated using forced entry of all covariates producing similar results (data not shown).”
RE:“;THE IMPACT OF CONFOUNDER SELECTION CRITERIA ON EFFECT ESTIMATION”
Greenland, S., & Mickey, R. M. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115409 · Cited by 2,108
Ronco, C., Haapio, M., House, A. A., Anavekar, N., & Bellomo, R. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.051 · Cited by 1,883
Ronco, C., McCullough, P., Anker, S. D., Anand, I., Aspromonte, N., Bagshaw, S. M., Bellomo, R., Berl, T., Bobek, I., Cruz, D. N., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp507 · Cited by 1,104
Forman, D. E., Butler, J., Wang, Y., Abraham, W. T., O'Connor, C. M., Gottlieb, S. S., Loh, E., Massie, B. M., Rich, M. W., Stevenson, L. W., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.07.031 · Cited by 912
Dries, D. L., Exner, D. V., Domanski, M. J., Greenberg, B., & Stevenson, L. W. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00608-7 · Cited by 879 · cited 1×
“19 Additionally, the strong association between baseline renal dysfunction and reduced survival has been previously described in both asymptomatic and symptomatic patients in the SOLVD dataset.(23) Characteristics of the 6,377 patients with data on renal function both at baseline and 14 days are presented in Table 1.”
Self-citationBakris, G. L., & Weir, M. R. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.5.685 · Cited by 823
Cited by
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Authors/Task Force Members:, McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2333 · Cited by 2,171
Damman, K., Valente, M. A. E., Voors, A. A., O'Connor, C. M., van Veldhuisen, D. J., & Hillege, H. L. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht386 · Cited by 1,125
The kidney in heart failure: an update
Damman, K., & Testani, J. M. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv010 · Cited by 519
Self-citationMetra, M., Davison, B., Bettari, L., Sun, H., Edwards, C., Lazzarini, V., Piovanelli, B., Carubelli, V., Bugatti, S., Lombardi, C., et al. (2012) · Circulation: Heart Failure · doi:10.1161/circheartfailure.111.963413 · Cited by 492
Ahmad, T., Jackson, K., Rao, V. S., Tang, W. H. W., Brisco-Bacik, M. A., Chen, H. H., Felker, G. M., Hernandez, A. F., O’Connor, C. M., Sabbisetti, V. S., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.030112 · Cited by 360
Self-citationHollenberg, S. M., Warner Stevenson, L., Ahmad, T., Amin, V. J., Bozkurt, B., Butler, J., Davis, L. L., Drazner, M. H., Kirkpatrick, J. N., Peterson, P. N., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.08.001 · Cited by 336
Cardiorenal Syndrome Revisited
Zannad, F., & Rossignol, P. (2018) · Circulation · doi:10.1161/circulationaha.117.028814 · Cited by 335
Testani, J. M., Brisco, M. A., Turner, J. M., Spatz, E. S., Bellumkonda, L., Parikh, C. R., & Tang, W. H. W. (2014) · Circulation: Heart Failure · doi:10.1161/circheartfailure.113.000895 · Cited by 296
Self-citationVardeny, O., Wu, D. H., Desai, A., Rossignol, P., Zannad, F., Pitt, B., & Solomon, S. D. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.048 · Cited by 272
Kraus, B. J., Weir, M. R., Bakris, G. L., Mattheus, M., Cherney, D. Z. I., Sattar, N., Heerspink, H. J. L., Ritter, I., von Eynatten, M., Zinman, B., et al. (2021) · Kidney International · doi:10.1016/j.kint.2020.10.031 · Cited by 219
Renal sodium avidity in heart failure: from pathophysiology to treatment strategies
Mullens, W., Verbrugge, F. H., Nijst, P., & Tang, W. H. W. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx035 · Cited by 202
“Besides their impact on remodelling and prognosis in HF, RAASblockers lead to increased diuretic and natriuretic capacity in chronic (and acute HF), even in the face of a potential drop in GFR when therapy is initiated.(94)”
BackgroundKumar, U., Wettersten, N., & Garimella, P. S. (2019) · Cardiology Clinics · doi:10.1016/j.ccl.2019.04.001 · Cited by 178
Beldhuis, I. E., Streng, K. W., Ter Maaten, J. M., Voors, A. A., van der Meer, P., Rossignol, P., McMurray, J. J. V., & Damman, K. (2017) · Circulation: Heart Failure · doi:10.1161/circheartfailure.116.003588 · Cited by 126
“The CONSENSUS (Cooperative North Scandinavian Enalapril Survival Study) demonstrated a reduction in mortality with ACE inhibition, despite an enalapril-induced increase in mean serum creatinine of 10% to 15% above baseline.19 In the SAVE (Survival and Ventricular Enlargement) study, mild to moderate chronic kidney dis…”
BackgroundInfluentialDamman, K., Tang, W. H. W., Felker, G. M., Lassus, J., Zannad, F., Krum, H., & McMurray, J. J. V. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.031 · Cited by 122
“Early WRF occurred in as much as 10% of patients in the SOLVD studies (66).”
BackgroundDamman, K., Solomon, S. D., Pfeffer, M. A., Swedberg, K., Yusuf, S., Young, J. B., Rouleau, J. L., Granger, C. B., & McMurray, J. J. V. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.609 · Cited by 75
Ohkuma, T., Jun, M., Rodgers, A., Cooper, M. E., Glasziou, P., Hamet, P., Harrap, S., Mancia, G., Marre, M., Neal, B., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12060 · Cited by 56
Metadata
- Authors
- Testani, J. M., Kimmel, S. E., Dries, D. L., & Coca, S. G.
- Venue
- Circulation: Heart Failure
- Published
- 2011-11
- Volume
- 4
- Issue
- 6
- Pages
- 685-691
- ISSN
- 1941-3289 (ISSN-L)
- 1941-3297
- OpenAlex
- W2169268865
- Cited by
- 245
- References
- 32
- FWCI
- 12.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.